Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis

OBJECTIVE: To evaluate the safety and efficacy of interventional therapy (iodine-125[(125)I] seed strand and portal vein stent [PVS] implantation plus transarterial chemoembolization [TACE]) combined with systemic therapy (lenvatinib plus anti-PD-1 antibody) as first-line treatment for hepatocellula...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Zi-Han, Hou, Si-Nan, Yu, Jia-Ze, Zhang, Wen, Ma, Jing-Qin, Yang, Min-Jie, Liu, Qing-Xin, Liu, Ling-Xiao, Luo, Jian-Jun, Qu, Xu-Dong, Yan, Zhi-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893110/
https://www.ncbi.nlm.nih.gov/pubmed/36741718
http://dx.doi.org/10.3389/fonc.2022.1086095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893110/
https://www.ncbi.nlm.nih.gov/pubmed/36741718
http://dx.doi.org/10.3389/fonc.2022.1086095

Ejemplares similares